Back to investors
DECHENG CAPITAL LLC
DECHENG CAPITAL LLC
Latest filing: 2026-06-30
DECHENG CAPITAL LLC runs DECHENG CAPITAL LLC and currently holds 14 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $731.75M. Their top holdings are CGON, NUVB, ACRS, RCUS, RVMD. The top five represent 88.2% of reported portfolio weight. DECHENG CAPITAL LLC ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, DECHENG CAPITAL LLC initiated 1 new position. They trimmed 3 positions. Their current best-performing preview position is RVMD with returns of +92.58%.
Sign in to enable email alerts for this investor.
Showper page
14 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 CGON CG ONCOLOGY INC | 61.87% | $40.77 | $79.81 | +95.76% | Held |
 NUVB Nuvation Bio Inc. | 20.15% | $2.52 | $6.93 | +174.80% | Held |
 ACRS Aclaris Therapeutics, Inc. | 2.92% | $2.06 | $6.41 | +211.17% | Held |
 RCUS Arcus Biosciences, Inc | 1.96% | $15.21 | $30.34 | +99.47% | Trimmed -2.73% |
 RVMD REVOLUTION MEDICINES INC(NSM) | 1.35% | $43.75 | $209.46 | +378.77% | Trimmed -43.67% |
 NAMS NEWAMSTERDAM PHARMA CO NV | 0.82% | $20.79 | $27.87 | +34.05% | Trimmed -45.58% |
 TNGX TANGO THERAPEUTICS INC | 0.09% | $31.26 | $23.88 | -23.61% | New Buy |
Showing 1-10 of 14